{"id":925671,"date":"2026-01-08T19:01:32","date_gmt":"2026-01-09T00:01:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/"},"modified":"2026-01-08T19:01:32","modified_gmt":"2026-01-09T00:01:32","slug":"emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/","title":{"rendered":"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026"},"content":{"rendered":"
\n

GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) — Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax\u00ae <\/sup>(Anthrax Vaccine Adsorbed) in 2026. This order is under Emergent\u2019s\u00a0existing indefinite-delivery\/indefinite-quantity (IDIQ) contract<\/a> (W911SR24D0001), led by the Capability Program Executive Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), previously the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency.<\/p>\n

\u201cAs part of our mission to protect and save lives, we\u2019re proud to help protect those who protect us, including our nation\u2019s service members,\u201d said Paul Williams, senior vice president, head of products business, global government and public affairs at Emergent. \u201cWe\u2019re pleased to continue our partnership with the U.S. Department of War to supply BioThrax\u00ae <\/sup>to prepare military personnel at high risk of anthrax exposure.\u201d<\/p>\n

Deliveries under this order will take place in 2026. This order includes a one-year base period, with two additional option periods for 2027 and 2028.<\/p>\n

\n About\u00a0BioThrax<\/strong>
\n \u00ae<\/sup>
\n \u00a0(Anthrax Vaccine Adsorbed)<\/strong>\u00a0
BioThrax\u00ae\u00a0<\/sup>vaccine is\u00a0indicated\u00a0for the active immunization for the prevention of disease caused by\u00a0Bacillus anthracis<\/em>\u00a0in persons 18 through 65 years of age.\u00a0BioThrax\u00ae\u00a0<\/sup>is approved for\u00a0(1)\u00a0pre-exposure prophylaxis of disease in persons at\u00a0high risk\u00a0of exposure; and (2)\u00a0post-exposure prophylaxis of disease following suspected or confirmed\u00a0Bacillus anthracis<\/em>\u00a0exposure, when administered in conjunction with recommended antibacterial drugs.\u00a0The efficacy of\u00a0BioThrax\u00ae\u00a0<\/sup>for post-exposure prophylaxis is based solely on studies in animal models of inhalational anthrax.\u00a0<\/p>\n

\n Select\u00a0Important Safety Information<\/strong>\u00a0<\/p>\n

\n Contraindication<\/strong>: Severe allergic reaction (e.g., anaphylaxis) after\u00a0a previous\u00a0dose of\u00a0BioThrax\u00ae\u00a0<\/sup>or a\u00a0component\u00a0of the vaccine.\u00a0Warnings and Precautions<\/strong>:\u00a0<\/strong>Latex<\/u><\/em>: The stopper of the vial\u00a0contains\u00a0natural rubber latex and may cause allergic reactions in latex sensitive individuals.\u00a0Pregnancy<\/u><\/em>: Avoid use in pregnancy unless the potential benefit outweighs the potential risk to the fetus.\u00a0Adverse Reactions:\u00a0<\/strong>The most common (>10%) local (injection-site) adverse reactions\u00a0observed\u00a0in\u00a0clinical studies were tenderness, pain, erythema, edema, and arm motion limitation. The most common (\u22655%) systemic adverse reactions were muscle aches, fatigue, and\u00a0headache.\u00a0<\/p>\n

Please see\u00a0the\u00a0full\u00a0Prescribing Information<\/a>\u00a0for\u00a0BioThrax\u00ae\u00a0<\/sup>for\u00a0additional\u00a0safety\u00a0information.\u00a0<\/p>\n

\n Disclaimer:<\/strong> The views and opinions expressed herein regarding any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise do not necessarily constitute or imply endorsement, recommendation, or favoring by the United States government and shall not be used for advertising or product endorsement purposes.\u00a0<\/p>\n

\n About\u00a0Emergent BioSolutions<\/strong>
\n
At Emergent, our mission is to protect and save lives. For over 25 years, we\u2019ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today\u2019s health challenges and tomorrow\u2019s threats, visit our\u00a0website<\/a>\u00a0and follow us on\u00a0LinkedIn<\/a>,\u00a0X<\/a>,\u00a0Instagram<\/a>,\u00a0Apple Podcasts<\/a>\u00a0and\u00a0Spotify<\/a>.\u00a0<\/p>\n

\n Investor Contact:<\/strong>
\n
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com<\/a><\/p>\n

\n Media Contact:<\/strong>
\n
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) — Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) in 2026. This order is under Emergent\u2019s\u00a0existing indefinite-delivery\/indefinite-quantity (IDIQ) contract (W911SR24D0001), led by the Capability Program Executive Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), previously the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency. \u201cAs part of our mission to protect and save lives, we\u2019re proud to help protect those who protect us, including our nation\u2019s service members,\u201d said Paul Williams, senior vice president, head of products business, global government … <\/p>\n

Continue reading “Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-925671","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEmergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) — Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) in 2026. This order is under Emergent\u2019s\u00a0existing indefinite-delivery\/indefinite-quantity (IDIQ) contract (W911SR24D0001), led by the Capability Program Executive Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), previously the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency. \u201cAs part of our mission to protect and save lives, we\u2019re proud to help protect those who protect us, including our nation\u2019s service members,\u201d said Paul Williams, senior vice president, head of products business, global government … Continue reading "Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-09T00:01:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026\",\"datePublished\":\"2026-01-09T00:01:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/\"},\"wordCount\":539,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/\",\"name\":\"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY=\",\"datePublished\":\"2026-01-09T00:01:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/","og_locale":"en_US","og_type":"article","og_title":"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026 - Market Newsdesk","og_description":"GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) — Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) in 2026. This order is under Emergent\u2019s\u00a0existing indefinite-delivery\/indefinite-quantity (IDIQ) contract (W911SR24D0001), led by the Capability Program Executive Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), previously the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency. \u201cAs part of our mission to protect and save lives, we\u2019re proud to help protect those who protect us, including our nation\u2019s service members,\u201d said Paul Williams, senior vice president, head of products business, global government … Continue reading \"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-09T00:01:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026","datePublished":"2026-01-09T00:01:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/"},"wordCount":539,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/","name":"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY=","datePublished":"2026-01-09T00:01:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU1NiM3MzUxNzkzIzIwMTA4NjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emergent-biosolutions-receives-delivery-order-up-to-21-5-million-to-supply-biothrax-anthrax-vaccine-adsorbed-to-the-u-s-department-of-war-in-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax\u00ae (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=925671"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925671\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=925671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=925671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=925671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}